ARAI

INDIANAPOLIS, IN / ACCESS Newswire / September 3, 2026 / Arrive AI (NASDAQ:ARAI), a physical AI and autonomous logistics infrastructure company enabling drones, robots, autonomous mobile robots (AMRs), autonomous vehicles (AVs) and human couriers to securely exchange goods, today announced that members of the company's leadership team will present and host one-on-one investor meetings at the 28th Annual H.C. Wainwright Global Investment Conference on September 14-16, 2026 at the Lotte New York Palace Hotel in New York City.

Company expects approximately $1.5 million in annualized savings as a more focused, AI-enabled operating model allows Arrive AI to streamline its organization; approximately 450,000 unvested shares forfeited INDIANAPOLIS, IN / ACCESS Newswire / August 19, 2026 / Arrive AI (NASDAQ:ARAI), a physical AI and autonomous logistics infrastructure company enabling drones, robots, autonomous mobile robots (AMRs), autonomous vehicles (AVs) and human couriers to securely exchange goods, today announced a strategic recalibration of its workforce and operating model as the Company moves ahead of schedule toward a leaner, more focused and increasingly AI-enabled organization. The actions are expected to generate approximately $1.5 million in annualized cost savings while aligning the Company's resources more closely with its current strategic and commercialization priorities.

New Unsecured Promissory Note in the Amount of $108,000 With Streeterville Lowers Applicable Floor Price From $0.25 to $0.10 and Removes Approximately $962,500 in Mandatory Monthly Cash Repayment Obligations Previously Triggered Under the Financing Agreement INDIANAPOLIS, IN / ACCESS Newswire / August 19, 2026 / Arrive AI (NASDAQ:ARAI), a physical AI and autonomous logistics infrastructure company enabling drones, robots, autonomous mobile robots (AMRs), autonomous vehicles (AVs) and human couriers to securely exchange goods, today announced a favorable amendment to its financing agreement with Streeterville Capital, LLC that the Company believes resolves a previously triggered $962,500 mandatory monthly cash repayment requirement and provides the Company with increased financial and operating flexibility. In connection with the new promissory note, the applicable floor price has been reduced from $0.25 to $0.10 per share.

Arrive AI Inc. (ARAI) Q2 2026 Earnings Call Transcript

Accomplished Wall Street Executive, Piyush Phadke, Appointed CFO, bringing 20+ Years of Capital Markets Experience to Help Drive Arrive AI's Growth INDIANAPOLIS, IN / ACCESS Newswire / August 13, 2026 / Arrive AI (NASDAQ:ARAI) (the "Company"), an autonomous delivery network company built around patented, AI-powered Arrive Points™, today reported financial results for the second quarter ended June 30, 2026, and provided an update on its commercial pipeline progress, product development, and operational milestones. In addition, the Company announced the appointment of Mr.

The program would pair licensed drone carriers with Arrive Points to bring secure, autonomous pharmacy delivery to Indianapolis-area patients INDIANAPOLIS, IN / ACCESS Newswire / August 4, 2026 / Arrive AI (NASDAQ:ARAI), an autonomous delivery network company built around patented, AI-powered Arrive Points™, today announced it has signed a letter of intent ("LOI") with LifeSpan Pharmacy, LLC, an Indianapolis-based pharmacy provider, to explore a collaborative program to develop and deploy an autonomous, drone-based pharmacy delivery network. Under the terms of the LOI, the parties intend to pursue a phased approach.

Live event will review Q2 results and cover recent business developments INDIANAPOLIS, IN / ACCESS Newswire / July 30, 2026 / Arrive AI (NASDAQ:ARAI), an autonomous delivery network company built around patented, AI-powered Arrive Points™, announced today that it plans to release its second quarter 2026 financial results on Thursday, August 13, 2026, before the market opens. After the earnings release goes out, members of Arrive AI's leadership team will host a conference call and webcast at 8:30 AM Eastern Time to review the results, talk through recent developments, and address the company's strategic and operational goals.

Head of Commercialization Ian Geise will represent the company at the event in New Orleans NEW ORLEANS, LA / ACCESS Newswire / July 15, 2026 / Arrive AI (Nasdaq:ARAI), an autonomous delivery network company built around patented, AI-powered Arrive Points™, today announced it will attend the NACUFS National Conference in New Orleans from July 15 to 18, 2026. Ian Geise, Arrive AI's Head of Commercialization, will represent the company as a delegate.

NEW YORK CITY, NY / ACCESS Newswire / June 4, 2026 / Arrive AI (NASDAQ:ARAI), an autonomous delivery network company building AI-powered last inch delivery infrastructure through secure, climate-assisted Arrive Points, today announced that members of the company's leadership team will participate in a fireside chat and host one-on-one investor meetings at the Jefferies Innovative Aerospace Virtual Summit on June 8, 2026. "Autonomous delivery is emerging as one of the more visible applications of intelligent, connected infrastructure, particularly as robots, drones and other aerial delivery systems move closer to widespread deployment," said Dan O'Toole, Founder and Chief Executive Officer of Arrive AI.

Expansion builds on successful hospital deployment and advances autonomous healthcare logistics across Hancock Health system INDIANAPOLIS, IN / ACCESS Newswire / May 28, 2026 / Arrive AI (NASDAQ:ARAI), an autonomous delivery network company built around patented, AI-powered Arrive Points™, today announced that Hancock Health is expanding its Arrive AI autonomous logistics network to include the Parkway outpatient facility in Greenfield, Indiana. The expansion builds on the successful deployment of Arrive AI's autonomous logistics system inside Hancock Regional Hospital and represents another major step forward in Hancock Health's broader initiative to modernize laboratory operations, improve workflow efficiency, and enhance patient experience through workflow-first automation.